Item 15. Exhibits, Financial Statement Schedules

22K characters. Original on sec.gov · Markdown

Item 15. Exhibits, Financial Statement Schedules

(a) 1. Financial Statement Schedules

The following Consolidated Financial Statements are included in Part II, Item 8-Financial Statements and Supplementary Data of this Annual Report on Form 10-K.

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets - December 31, 2019 and 2018

Consolidated Statements of Operations - for the years ended December 31, 2019, 2018 and 2017

Consolidated Statements of Comprehensive Income (Loss) - for the years ended December 31, 2019, 2018 and 2017

Consolidated Statements of Equity - for the years ended December 31, 2019, 2018 and 2017

Consolidated Statements of Cash Flows - for the years ended December 31, 2019, 2018 and 2017

Notes to Consolidated Financial Statements

(a) 2. Financial Statement Schedules

The following Consolidated Financial Statements are included in Part II, Item 8-Financial Statements and Supplementary Data of this Annual Report on Form 10-K.

Schedule II: Valuation and Qualifying Accounts

Schedule III: Real Estate and Accumulated Depreciation

Schedule IV: Mortgage Loans on Real Estate

(a) 3.Exhibits
ExhibitIncorporated by reference herein
NumberDescriptionFormDate Filed
3.1Articles of Restatement of Healthpeak Properties, Inc. (formerly HCP, Inc.) dated June 1, 2012, as supplemented by the Articles Supplementary, dated July 31, 2017, and as amended by the Articles of Amendment, dated October 30, 2019.†
3.2Sixth Amended and Restated Bylaws of Healthpeak, Properties, Inc., dated October 30, 2019.Current Report on Form 8-K (File No. 001-08895)October 30, 2019
4.1Indenture, dated as of September 1, 1993, between Healthpeak and The Bank of New York, as Trustee.Registration Statement on Form S‑3/A (Registration No. 333‑86654)May 21, 2002
4.1.1First Supplemental Indenture dated as of January 24, 2011, to the Indenture, dated as of September 1, 1993, by and between Healthpeak and The Bank of New York Mellon Trust Company, N.A., as Trustee.Current Report on Form 8‑K (File No. 001‑08895)January 24, 2011
4.2Indenture, dated November 21, 2012, between Healthpeak and The Bank of New York Mellon Trust Company, N.A., as trustee.Current Report on Form 8‑K (File No. 001‑ 08895)November 19, 2012
4.2.2Second Supplemental Indenture, dated November 12, 2013, between Healthpeak and The Bank of New York Mellon Trust Company, N.A., as trustee.Current Report on Form 8‑K (File No. 001‑08895)November 13, 2013
4.2.3Third Supplemental Indenture dated February 21, 2014, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee.Current Report on Form 8‑K (File No. 001‑08895)February 24, 2014
4.2.4Fourth Supplemental Indenture, dated August 14, 2014, between Healthpeak and The Bank of New York Mellon Trust Company, N.A., as trustee.Current Report on Form 8‑K (File No. 001‑08895)August 14, 2014
4.2.5Fifth Supplemental Indenture, dated January 21, 2015, between Healthpeak and The Bank of New York Mellon Trust Company, N.A., as trustee.Current Report on Form 8‑K (File No. 001‑08895)January 21, 2015
4.2.6Sixth Supplemental Indenture, dated May 20, 2015, between Healthpeak and The Bank of New York Mellon Trust Company, N.A., as trustee.Current Report on Form 8‑K (File No. 001‑08895)May 20, 2015
4.2.8Eighth Supplemental Indenture dated July 5, 2019, between Healthpeak and The Bank of New York Mellon Trust Company, N.A., as trustee.Current Report on Form 8‑K (File No. 001‑08895)July 5, 2019
4.2.9Ninth Supplemental Indenture dated November 19, 2019, between Healthpeak and The Bank of New York Mellon Trust Company, N.A., as trustee.Current Report on Form 8‑K (File No. 001‑08895)November 21, 2019
4.3Form of 6.750% Senior Notes due 2041.Current Report on Form 8‑K (File No. 001‑08895)January 24, 2011
4.4Form of 3.15% Senior Notes due 2022.Current Report on Form 8‑K (File No. 001‑08895)July 23, 2012
4.6Form of 4.250% Senior Notes due 2023.Current Report on Form 8‑K (File No. 001‑08895)November 13, 2013
4.7Form of 4.20% Senior Notes due 2024.Current Report on Form 8‑K (File No. 001‑08895)February 24, 2014
4.8Form of 3.875% Senior Notes due 2024.Current Report on Form 8‑K (File No. 001‑08895)August 14, 2014
4.9Form of 3.400% Senior Notes due 2025.Current Report on Form 8‑K (File No. 001‑08895)January 21, 2015
4.10Form of 4.000% Senior Notes due 2025.Current Report on Form 8‑K (File No. 001‑08895)May 20, 2015
4.12Form of 3.250% Senior Notes due 2026.Current Report on Form 8‑K (File No. 001‑08895)July 5, 2019
4.13Form of 3.500% Senior Notes due 2029.Current Report on Form 8‑K (File No. 001‑08895)July 5, 2019
4.14Form of 3.000% Senior Notes due 2030.Current Report on Form 8‑K (File No. 001‑08895)November 21, 2019
4.15Description of Healthpeak Capital Stock†
10.1Second Amended and Restated Director Deferred Compensation Plan.*Quarterly Report on Form 10‑Q (File No. 001‑08895)November 3, 2009
10.2Non-Employee Directors Stock-for-Fees Program.*Quarterly Report on Form 10-Q (File No. 001‑08895)August 5, 2014
10.3Executive Severance Plan.*Quarterly Report on Form 10-Q (File No. 001-08895)November 1, 2016
10.4Executive Change in Control Severance Plan (as Amended and Restated as of May 6, 2016).*Quarterly Report on Form 10-Q (File No. 001 08895)November 1, 2016
10.52006 Performance Incentive Plan, as amended and restated.*Annex 2 to HCP’s Proxy Statement (File No. 001‑08895)March 10, 2009
10.5.1Form of Employee 2006 Performance Incentive Plan Nonqualified Stock Option Agreement.*Quarterly Report on Form 10‑Q (File No. 001‑08895)May 1, 2012
10.6Amended and Restated Healthpeak Properties, Inc. 2014 Performance Incentive Plan, as amended through October 24, 2019.†*
10.6.1Form of 2014 Performance Incentive Plan Non-NEO Restricted Stock Unit Award Agreement (adopted 2014).*Quarterly Report on Form 10-Q (File No. 001‑08895)August 5, 2014
10.6.2Form of 2014 Performance Incentive Plan Non-NEO Option Agreement (adopted 2014).*Quarterly Report on Form 10-Q (File No. 001‑08895)August 5, 2014
10.6.3Form of 2014 Performance Incentive Plan CEO 3-Year LTIP RSU Agreement (adopted 2015).*Quarterly Report on Form 10-Q (File No. 001‑08895)May 5, 2015
10.6.4Form of 2014 Performance Incentive Plan CEO 1-Year LTIP RSU Agreement (adopted 2015).*Quarterly Report on Form 10-Q (File No. 001‑08895)May 5, 2015
10.6.5Form of 2014 Performance Incentive Plan CEO Retentive LTIP RSU Agreement (adopted 2015).*Quarterly Report on Form 10-Q (File No. 001‑08895)May 5, 2015
10.6.6Form of 2014 Performance Incentive Plan NEO 3-Year LTIP RSU Agreement (adopted 2015).*Quarterly Report on Form 10-Q (File No. 001‑08895)May 5, 2015
10.6.7Form of 2014 Performance Incentive Plan NEO 3-Year LTIP RSU Agreement (adopted 2018).*Quarterly Report on Form 10-Q (File No. 001‑08895)May 3, 2018
10.6.8Form of 2014 Performance Incentive Plan NEO 3-Year LTIP RSU Agreement (adopted 2019).*Quarterly Report on Form 10-Q (File No. 001‑08895)May 2, 2019
10.6.9Form of 2014 Performance Incentive Plan NEO 1-Year LTIP RSU Agreement (adopted 2015).*Quarterly Report on Form 10-Q (File No. 001‑08895)May 5, 2015
10.6.10Form of 2014 Performance Incentive Plan NEO Retentive LTIP RSU Agreement (adopted 2015).*Quarterly Report on Form 10-Q (File No. 001‑08895)May 5, 2015
10.6.11Form of 2014 Performance Incentive Plan NEO Retentive LTIP RSU Agreement (adopted 2018).*Quarterly Report on Form 10-Q (File No. 001‑08895)May 3, 2018
10.6.12Form of 2014 Performance Incentive Plan NEO Retentive LTIP RSU Agreement (adopted 2019).*Quarterly Report on Form 10-Q (File No. 001‑08895)May 2, 2019
10.6.13Form of 2014 Performance Incentive Plan Non-Employee Director RSU Agreement.*Quarterly Report on Form 10-Q (File No. 001‑08895)May 5, 2015
10.7Form of Directors and Officers Indemnification Agreement.*Annual Report on Form 10‑K, as amended (File No. 001‑08895)February 12, 2008
10.8Amended and Restated Dividend Reinvestment and Stock Purchase Plan.Registration Statement on Form S‑3 (Registration No. 333‑49746)November 13, 2000
10.9Amended and Restated Limited Liability Company Agreement of HCPI/Utah, LLC, dated as of January 20, 1999.Annual Report on Form 10‑K (File No. 001‑ 08895)March 29, 1999
10.9.1Amendments No. 1-9 to Amended and Restated Limited Liability Company Agreement of HCPI/Utah, LLC, dated as of January 20, 1999.Annual Report on Form 10-K (File No. 001-08895)February 13, 2018
10.9.2Tax Matters Amendment to Amended and Restated Limited Liability Company Agreement of HCPI/Utah, LLC, effective as of December 31, 2018.Annual Report on Form 10-K (File No. 001-08895)February 14, 2019
10.10Amended and Restated Limited Liability Company Agreement of HCPI/Utah II, LLC, dated as of August 17, 2001, as amended.Current Report on Form 8‑K (File No. 001‑08895)November 9, 2012
10.10.1Tax Matters Amendment to Amended and Restated Limited Liability Company Agreement of HCPI/Utah II, LLC, effective as of December 31, 2018.Annual Report on Form 10-K (File No. 001-08895)February 14, 2019
10.11Amended and Restated Limited Liability Company Agreement of HCPI/Tennessee, LLC, dated as of October 2, 2003.Quarterly Report on Form 10‑Q (File No. 001‑ 08895)November 12, 2003
10.11.1Amendment No. 1 to Amended and Restated Limited Liability Company Agreement of HCPI/Tennessee, LLC, dated as of September 29, 2004.Quarterly Report on Form 10‑Q (File No. 001‑08895)November 8, 2004
10.11.2Amendment No. 2 to Amended and Restated Limited Liability Company Agreement of HCPI/Tennessee, LLC, dated as of October 27, 2004.Annual Report on Form 10‑K (File No. 001‑08895)March 15, 2005
10.11.3Amendment No. 3 to Amended and Restated Limited Liability Company Agreement of HCPI/Tennessee, LLC and New Member Joinder Agreement, dated as of October 19, 2005, by and among Healthpeak, HCPI/Tennessee, LLC and A. Daniel Weyland.Quarterly Report on Form 10‑Q (File No. 001‑08895)November 1, 2005
10.11.4Amendment No. 4 to Amended and Restated Limited Liability Company Agreement of HCPI/Tennessee, LLC, effective as of January 1, 2007.Annual Report on Form 10‑K, as amended (File No. 001‑08895)February 12, 2008
10.11.5Tax Matters Amendment to Amended and Restated Limited Liability Company Agreement of HCPI/Tennessee, LLC, effective as of December 31, 2018.Annual Report on Form 10-K (File No. 001-08895)February 14, 2019
10.12Amended and Restated Limited Liability Company Agreement of HCP DR MCD, LLC, dated as of February 9, 2007.Current Report on Form 8-K (File No. 001‑08895)April 20, 2012
10.12.1Tax Matters Amendment to Amended and Restated Limited Liability Company Agreement of HCP DR MCD, LLC, effective as of December 31, 2018.Annual Report on Form 10-K (File No. 001-08895)February 14, 2019
10.13Amended and Restated Limited Liability Company Agreement of HCP DR California II, LLC, dated as of June 1, 2014.Quarterly Report on Form 10-Q (File No. 001‑08895)August 5, 2014
10.13.1Tax Matters Amendment to Amended and Restated Limited Liability Company Agreement of HCP DR California II, LLC, effective as of December 31, 2018.Annual Report on Form 10-K (File No. 001-08895)February 14, 2019
10.14Amended and Restated Limited Liability Company Agreement of HCP DR California III, LLC, dated as of May 1, 2019.Quarterly Report on Form 10-Q (File No. 001‑08895)August 1, 2019
10.15Second Amended and Restated Limited Liability Company Agreement of SH DR California IV, LLC, dated as of July 18, 2019.Quarterly Report on Form 10-Q (File No. 001‑08895)October 31, 2019
10.16Amended and Restated Credit Agreement, dated as of May 23, 2019, by and among Healthpeak, as borrower, the lenders referred to therein, and Bank of America, N.A., as administrative agent.Current Report on Form 8‑K (File No. 001‑08895)May 23, 2019
10.17At-the-Market Equity Offering Sales Agreement, dated February 26, 2019, among Healthpeak and the sales agents, forward sellers and forward purchasers referred to therein.Current Report on Form 8-K (File No. 001-08895)February 26, 2019
21.1Subsidiaries of the Company.†
23.1Consent of Independent Registered Public Accounting Firm—Deloitte & Touche LLP.†
31.1Certification by Thomas M. Herzog, Healthpeak’s Principal Executive Officer, Pursuant to Securities Exchange Act Rule 13a‑14(a).††
31.2Certification by Peter A. Scott, Healthpeak’s Principal Financial Officer, Pursuant to Securities Exchange Act Rule 13a‑14(a).††
32.1Certification by Thomas M. Herzog, Healthpeak’s Principal Executive Officer, Pursuant to Securities Exchange Act Rule 13a‑14(b) and 18 U.S.C. Section 1350.†
32.2Certification by Peter A. Scott, Healthpeak’s Principal Financial Officer, Pursuant to Securities Exchange Act Rule 13a‑14(b) and 18 U.S.C. Section 1350.†
101.INSXBRL Instance Document.†
101.SCHXBRL Taxonomy Extension Schema Document.†
101.CALXBRL Taxonomy Extension Calculation Linkbase Document.†
101.DEFXBRL Taxonomy Extension Definition Linkbase Document.†
101.LABXBRL Taxonomy Extension Labels Linkbase Document.†
101.PREXBRL Taxonomy Extension Presentation Linkbase Document.†
104Cover Page Interactive Data File (embedded within the Inline XBRL document).

_______________________________________

*Management Contract or Compensatory Plan or Arrangement.
†Filed herewith.
††Furnished herewith.

Previous: Item 14. Principal Accounting Fees and Services · Next: Item 16. Form 10-K Summary